Literature DB >> 14530196

Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting.

PierMarco Piatti1, Carlo Di Mario, Lucilla D Monti, Gabriele Fragasso, Fabio Sgura, Andrea Caumo, Emanuela Setola, Pietro Lucotti, Elena Galluccio, Cristina Ronchi, Anna Origgi, Ivana Zavaroni, Alberto Margonato, Antonio Colombo.   

Abstract

BACKGROUND: Previously undiagnosed diabetes, impaired glucose tolerance, and insulin resistance are common in patients with acute myocardial infarction and coronary heart disease (CHD) and might be involved in early restenosis after stent implantation. To evaluate whether markers of insulin resistance syndrome, including leptin, and endothelial dysfunction are related to increased rate of early restenosis, we studied nondiabetic patients with CHD after successful coronary stenting. METHODS AND
RESULTS: Both patients with CHD undergoing coronary stenting (120 patients) and control subjects (58 patients) were submitted to an oral glucose tolerance test (OGTT). Fasting leptin levels and fasting and postglucose load insulin sensitivity were assessed. Endothelial function was measured by nitrite and nitrate release (NOx) during OGTT. More than 50% of patients treated with stent implantation presented impaired glucose tolerance or type 2 diabetes, which was previously undiagnosed. These patients also had higher glucose, insulin, and leptin levels than control subjects. Among the stented patients, insulin and leptin levels were higher in patients with restenosis than in patients without restenosis. A significant increase in NOx levels was found during OGTT both in patients without restenosis and in control subjects. On the contrary, NOx profiles were blunted in patients with restenosis. At multiple regression analysis, only DeltaAUC-NOx areas and insulin sensitivity index showed an independent correlation with the minimal lumen diameter at follow-up.
CONCLUSIONS: We demonstrated that insulin resistance and endothelial dysfunction are independent predictors of early restenosis after coronary stenting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530196     DOI: 10.1161/01.CIR.0000095272.67948.17

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

1.  Oxidative stress in the metabolic syndrome.

Authors:  K Esposito; M Ciotola; B Schisano; L Misso; G Giannetti; A Ceriello; D Giugliano
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 2.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

3.  Leptinemia is Associated With Peripheral Artery Disease.

Authors:  Greg J Zahner; Joel L Ramirez; Kimberly A Spaulding; Sukaynah A Khetani; Warren J Gasper; Carl Grunfeld; Nancy K Hills; Anne L Schafer; S Marlene Grenon
Journal:  J Surg Res       Date:  2019-02-06       Impact factor: 2.192

Review 4.  Effect of CPAP therapy on liver disease in patients with OSA: a review.

Authors:  Xin Liu; Yuyang Miao; Fan Wu; Tingting Du; Qiang Zhang
Journal:  Sleep Breath       Date:  2018-01-11       Impact factor: 2.816

5.  Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?

Authors:  Julie Anna Bienertová-Vasků; Ota Hlinomaz; Anna Vasků
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

6.  Nox2 contributes to cardiac fibrosis in diabetic cardiomyopathy in a transforming growth factor-β dependent manner.

Authors:  Yuqin Liu; Jinhua Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 7.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

8.  Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey.

Authors:  Stephen M Amrock; Michael Weitzman
Journal:  Atherosclerosis       Date:  2014-06-23       Impact factor: 5.162

Review 9.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

10.  The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.

Authors:  Omar M Kaisar; David W Johnson; Judith B Prins; Nicole Isbel
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.